Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

Información selecta para pacientes y cuidadores que se encuentra disponible en Español.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

IBRANCE® capsules Principal Display Panel (palbociclib)

PRINCIPAL DISPLAY PANEL - 75 mg Capsule Bottle Label

NDC 0069-0187-21

Pfizer

Ibrance®
(palbociclib)
capsules

75 mg

21 Capsules

Rx only

PRINCIPAL DISPLAY PANEL - 75 mg Capsule Bottle Label

PRINCIPAL DISPLAY PANEL - 100 mg Capsule Bottle Label

NDC 0069-0188-21

Pfizer

Ibrance®
(palbociclib)
capsules

100 mg

21 Capsules

Rx only

PRINCIPAL DISPLAY PANEL - 100 mg Capsule Bottle Label

PRINCIPAL DISPLAY PANEL - 125 mg Capsule Bottle Label

NDC 0069-0189-21

Pfizer

Ibrance®
(palbociclib)
capsules

125 mg

21 Capsules

Rx only

PRINCIPAL DISPLAY PANEL - 125 mg Capsule Bottle Label
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event